Rosette-forming glioneuronal tumor: an update

  • C. T. Anyanwu
  • T. M. Robinson
  • J. H. Huang
Review Article


Rosette-forming glioneuronal tumor (RGNT) is a rare and distinct primary nervous system tumor. The literature on this novel neoplasm is sparse and limited to mostly case reports. Reviews on the characteristics of this tumor are fewer and far between with the latest up to a decade old. We thus provide a comprehensive review of recent literature to characterize presenting symptoms, radiological evidence, treatment options, and prognosis of this novel neoplasm. A Medline search for case reports detailing primary rosette-forming glioneuronal tumors was performed. RGNTs are a benign tumor of indolent course with mixed glial and neurocytic components. There is a slight female predominance with mean age of presentation at 23.57 years. Headaches, visual disturbances, and nausea and vomiting are the most common symptoms. Most RGNTs have solid and cystic components, arising most frequently in the fourth ventricle or cerebellum. Management is usually through surgery with gross total resection (GTR) providing better prognosis.


Cerebellar mass RGNT Rosette-forming glioneuronal tumor Posterior fossa neoplasm Benign Brain tumor 



We would like to thank our librarian, Sheila Green for her assistance with the literature search for this review.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants and/or animals performed by any of the authors.

Informed consent

For this type of study, no informed consent is required.


  1. 1.
    Abdelzaher E: Rosette forming glioneuronal tumor (RGNT). website. Accessed 21 May 2019
  2. 2.
    Allende DS, Prayson RA. The expanding family of glioneuronal tumors. Adv Anat Pathol. 2009;16(1):33–9.CrossRefGoogle Scholar
  3. 3.
    Allinson KS, O'Donovan DG, Jena R, Cross JJ, Santarius TS. Rosette-forming glioneuronal tumor with dissemination throughout the ventricular system: a case report. Clin Neuropathol. 2015;34(2):64–9.CrossRefGoogle Scholar
  4. 4.
    Alturkustani M, Ang LC. Rosette-forming glioneuronal tumour of the 4th ventricle in a NF1 patient. Can J Neurol Sci. 2012;39(1):95–6.CrossRefGoogle Scholar
  5. 5.
    Anan M, Inoue R, Ishii K, Abe T, Fujiki M, Kobayashi H, et al. A rosette-forming glioneuronal tumor of the spinal cord: the first case of a rosette-forming glioneuronal tumor originating from the spinal cord. Hum Pathol. 2009;40:898–901.CrossRefGoogle Scholar
  6. 6.
    Beuriat PA, Tauziede-Espariat A, Pages M, Varlet P, Di Rocco F. Rosette-forming glioneuronal tumor outside the fourth ventricle: a case-based update. Childs Nerv Syst. 2016;32(1):65–8.CrossRefGoogle Scholar
  7. 7.
    Chen SY, Wang W, Wang LM, Lin QT, Zhao GG, Xu G, et al. Glioneuronal tumours with features of rosette-forming glioneuronal tumours of the fourth ventricle and dysembryoplastic neuroepithelial tumours: a report of three cases. Histopathology. 2016;68(3):378–87.CrossRefGoogle Scholar
  8. 8.
    Chiba K, Aihara Y, Eguchi S, Tanaka M, Komori T, Okada Y. Rosette-forming glioneuronal tumor of the fourth ventricle with neurocytoma component. Childs Nerv Syst. 2014;30(2):351–6.CrossRefGoogle Scholar
  9. 9.
    Collin A, Adle-Biassette H, Lecler A. Rosette-forming glioneuronal tumor of spinal Cord. World Neurosurg. 2018;119:242–3.CrossRefGoogle Scholar
  10. 10.
    Duan L, Zhang Y, Fu W, Geng S. Rosette-forming glioneuronal tumor originating from the spinal cord: report of 2 cases and literature review. World Neurosurg. 2017;98:875.e1–.e7.CrossRefGoogle Scholar
  11. 11.
    Eastin M, Shah KJ, Newell KL, Chamoun R. Rosette-forming glioneuronal tumor of the thalamus. Clin Neuropathol. 2016;35(5):326–8.CrossRefGoogle Scholar
  12. 12.
    Fushimi Y, Miyasaki A, Taki H, Aoyama K, Hirato J, Kanagaki M, et al. Rosette-forming glioneuronal tumor of the fourth ventricle with bilateral olivary degeneration. Jpn J Radiol. 2011;29(6):445–8.CrossRefGoogle Scholar
  13. 13.
    Gao L, Han F, Jin Y, Xiong J, Lv Y, Yao Z, et al. Imaging features of rosette-forming glioneuronal tumours. Clin Radiol. 2018;73(3):275–82.CrossRefGoogle Scholar
  14. 14.
    García Cabezas S, Serrano Blanch R, Sanchez-Sanchez R, Palacios Eito A. Rosette-forming glioneuronal tumour (RGNT) of the fourth ventricle: a highlyaggressive case. Brain Tumor Pathol. 2015;32(2):124–30.CrossRefGoogle Scholar
  15. 15.
    Gessi M, Waha A, Setty P, Waha A, Pietsch T. Analysis of KIAA1549-BRAF fusion status in a case of rosette-forming glioneuronal tumor of the fourth ventricle (RGNT). Neuropathology. 2011;31(6):654–7.CrossRefGoogle Scholar
  16. 16.
    Hakan T, Aker FV. Rosette-forming glioneuronal tumour of the fourth ventricle: case report and review of the literature. Folia Neuropathol. 2016;54(1):80–7.CrossRefGoogle Scholar
  17. 17.
    Hsu C, Kwan G, Lau Q, Bhuta S. Rosette-forming glioneuronal tumour: imaging features, histopathological correlation and a comprehensive review of literature. Br J Neurosurg. 2012;26(5):668–73.CrossRefGoogle Scholar
  18. 18.
    Jayapalan RR, Mun KS, Wong KT, Sia SF. Malignant transformation of a rosette-forming glioneuronal tumor with IDH1 mutation: a case report and literature review. World Neurosurg X. 2019;2:100006.CrossRefGoogle Scholar
  19. 19.
    Kemp S, Achan A, Ng T, Dexter MA. Rosette-forming glioneuronal tumour of the lateral ventricle in a patient with neurofibromatosis 1. J Clin Neurosci. 2012;19(8):1180–1.CrossRefGoogle Scholar
  20. 20.
    Kwon SM, Kim JH, Byun J, Kim YH, Hong SH, Cho YH, Kim CJ. Malignant Transformation of a Rosette-forming glioneuronal tumor to glioblastoma: a case report. World Neurosurg. 2019;19:31583–9.Google Scholar
  21. 21.
    Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803–20.CrossRefGoogle Scholar
  22. 22.
    Maiti TK, Arimappamagan A, Mahadevan A, Yasha TC, Pandey P, Santosh V. Rare pathologies in the posterior third ventricular region in children: case series and review. Pediatr Neurosurg. 2015;50(1):42–7.CrossRefGoogle Scholar
  23. 23.
    Medhi G, Prasad C, Saini J, Pendharkar H, Bhat MD, Pandey P, et al. Imaging features of rosette-forming glioneuronal tumours (RGNTs): a series of seven cases. Eur Radiol. 2016;26(1):262–70.CrossRefGoogle Scholar
  24. 24.
    Schlamann A, von Bueren AO, Hagel C, Zwiener I, Seidel C, Kortmann RD, et al. An individual patient data meta-analysis on characteristics and outcome of patients with papillary glioneuronal tumor, rosette glioneuronal tumor with neuropil-like islands and rosette forming glioneuronal tumor of the fourth ventricle. PLoS ONE. 2014;9(7):e101211.CrossRefGoogle Scholar
  25. 25.
    Scheithauer BW, Silva AI, Ketterling RP, Pula JH, Lininger JF, Krinock MJ. Rosette-forming glioneuronal tumor: report of a chiasmal-optic nerve example in neurofibromatosis type 1: special pathology report. Neurosurgery. 2009;64:E771–772.CrossRefGoogle Scholar
  26. 26.
    Sharma P, Swain M, Padua MD, Ranjan A, Lath R. Rosette-forming glioneuronal tumors: a report of two cases. Neurol India. 2011;59(2):276–80.CrossRefGoogle Scholar
  27. 27.
    Simmons DB, Clark ME, Mathis DA, Sladky JH. Rosette-forming glioneuronal tumour in a patient with multiple sclerosis. Histopathology. 2015;67(5):751–3.CrossRefGoogle Scholar
  28. 28.
    Sumitomo N, Ishiyama A, Shibuya M, Nakagawa E, Kaneko Y, Takahashi A, et al. Intractable epilepsy due to a rosette-forming glioneuronal tumor with a dysembryoplastic neuroepithelial background. Neuropathology. 2018;38(3):300–4.CrossRefGoogle Scholar
  29. 29.
    Tamura R, Miwa T, Ohira T, Yoshida K. Diagnosis and treatment for pure aqueductal tumor. J Clin Neurosci. 2017;44:260–3.CrossRefGoogle Scholar
  30. 30.
    Thurston B, Gunny R, Anderson G, Paine S, Thompson D, Jacques T, et al. Fourth ventricle rosette-forming glioneuronal tumour in children: an unusual presentation in an 8-year-old patient, discussion and review of the literature. Childs Nerv Syst. 2013;29(5):839–47.CrossRefGoogle Scholar
  31. 31.
    Yamamoto T, Matsubara T, Satomi K, Sakamoto N, Matsuda M, Muroi A, et al. Rosette-forming glioneuronal tumor originating in the hypothalamus. Brain Tumor Pathol. 2015;32(4):291–6.CrossRefGoogle Scholar
  32. 32.
    Yang C, Fang J, Li G, Li S, Ha T, Wang J, et al. Histopathological, molecular, clinical and radiological characterization of rosette-forming glioneuronal tumor in the central nervous system. Oncotarget. 2017;8(65):109175–90.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Yin B, Liu L, Chen XR, Li K, Geng DY. Rosette-forming glioneuronal tumor of the fourth ventricle. J Neuroradiol. 2012;39(2):129–30.CrossRefGoogle Scholar
  34. 34.
    Zhang J, Babu R, McLendon RE, Friedman AH, Adamson C. A comprehensive analysis of 41 patients with rosette-forming glioneuronal tumors of the fourth ventricle. J Clin Neurosci. 2013;20(3):335–41.CrossRefGoogle Scholar

Copyright information

© Federación de Sociedades Españolas de Oncología (FESEO) 2019

Authors and Affiliations

  1. 1.Texas A&M Health Science Center College of MedicineBryanUSA
  2. 2.Department of Neurosurgery, Baylor Scott & White HealthTempleUSA
  3. 3.RichmondUSA

Personalised recommendations